Zuidmeer-Jongejan, Laurian <br/><br/>
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.  [electronic resource] 

 -  International archives of allergy and immunology  2015 
 - 41-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1423-0097 
<br/><br/><label>Standard No.: </label>10.1159/000371657  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allergens--administration & dosage<br/>Animals<br/>Calcium-Binding Proteins--administration & dosage<br/>Carps--immunology<br/>Desensitization, Immunologic--methods<br/>Double-Blind Method<br/>Escherichia coli--genetics<br/>Female<br/>Fish Proteins--administration & dosage<br/>Food Hypersensitivity--immunology<br/>Gene Expression<br/>Humans<br/>Immunoglobulin E--blood<br/>Immunoglobulin G--blood<br/>Injections, Subcutaneous<br/>Lethal Dose 50<br/>Leukocytes, Mononuclear--immunology<br/>Male<br/>Mice<br/>Parvalbumins--administration & dosage<br/>Protein Folding<br/>Protein Stability<br/>Rabbits<br/>Recombinant Proteins--administration & dosage